🇺🇸 FDA
Pipeline program

AB801

ARC-27

Phase 1 small_molecule active

Quick answer

AB801 for Advanced Cancer is a Phase 1 program (small_molecule) at Arcus Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Arcus Biosciences
Indication
Advanced Cancer
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials